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’INTRODUCTION
Invasive and systemic fungal infections continue to be an
important cause of morbidity and mortality. During the past few
decades, the incidence of invasive mycoses has risen and now
ranks as the seventh most frequent cause of death due to
infectious disease in the United States.
1,2 The majority of
systemic-disease-causing fungal pathogens are acquired via the
respiratory tract through inhalation of spores or conidia. Lung
infection by respiratory fungal pathogens results in varying
degrees of pulmonary disease dependent on dose, host immu-
nological status, and natural virulence of the pathogen. Of
hospitalizations in the United States due to infection by di-
morphic fungi, over half are caused by the pathogen Histoplasma
capsulatum.
3
The dimorphism of Histoplasma capsulatum reﬂects both a
changeinmorphologyand a switch from a saprobic toa parasitic
lifestyle. In the environment, Histoplasma exists as mycelia,
extending septate hyphae into the local substrate for absorption
of nutrients. Inhalation of mycelial-produced conidia into the
lung exposes them to mammalian body temperatures, which
trigger their diﬀerentiation into pathogenic yeast cells.
4 This
temperature-controlled transition into yeast is absolutely neces-
sary for Histoplasma pathogenesis. Although the mycelia can
produceinfectiveconidia,myceliathemselvesarenonpathogenic
as Histoplasma cells locked in the mycelial-phase are unable to
cause disease.
5,6 Mycelia are thus designated the nonpathogenic
phase and yeast as the pathogenic phase with conidia being the
natural infective form. The extensive changes in gene expression
that characterize the yeast phase program include loci required
for Histoplasma pathogenesis.
7,8
The yeast form of Histoplasma is an adept intracellular patho-
gen, found almost exclusively within host phagocytic cells that
normally provide the ﬁrst line of protection against fungal
infections. Histoplasma combats the antimicrobial eﬀects of
phagocyte-produced reactive oxygen
9 and establishes a replica-
tion-permissive niche inside the phagocyte. However, we lack
many of the mechanistic details regarding how Histoplasma
establishes a successful infection and thrives within host phago-
cytes. To date, only a handful of virulence factors have been
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ABSTRACT: The dimorphic fungal pathogen Histoplasma
capsulatum causes respiratory and systemic disease. Within
the mammalian host, pathogenic Histoplasma yeast infect,
replicate within, and ultimately kill host phagocytes. Surpris-
ingly, few factors have been identiﬁed that contribute to
Histoplasma virulence. To address this deﬁciency, we have
deﬁned the constituents of the extracellular proteome using
LC-MS/MS analysis of the proteins in pathogenic-phase
culture ﬁltrates of Histoplasma. In addition to secreted Cbp1,
the extracellular proteome of pathogenic Histoplasma yeast
consists of 33 deduced proteins. The proteins include glyca-
nases, extracellular enzymes related to oxidative stress defense,
dehydrogenase enzymes, chaperone-like factors, and ﬁve novel
culture ﬁltrate proteins (Cfp’s). For independent veriﬁcation of
proteomics-derived identities, we employed RNA interference
(RNAi)-baseddepletionofcandidatefactorsandshowedlossofspeciﬁcproteinsfromthecell-freecultureﬁltrate.QuantitativeRT-
PCR revealed the expression of 10 of the extracellular factors was particularly enriched in pathogenic yeast cells as compared to
nonpathogenicHistoplasmamycelia,suggestingthattheseproteinsarelinkedtoHistoplasmapathogenesis.Inaddition,Histoplasma
yeast express these factors within macrophages and during infection of murine lungs. As extracellular proteins are positioned at the
interface between host and pathogen, the deﬁnition of the pathogenic-phase extracellular proteome provides a foundation for the
molecular dissection of how Histoplasma alters the host-pathogen interaction to its advantage.
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identiﬁedforHistoplasma: mechanismsforironacquisition;
10-12
a secreted protein of unknown function (Cbp1);
13 an extracel-
lular yeast phase speciﬁc factor (Yps3);
14 and a cell wall poly-
saccharide (R-(1,3)-glucan).
15
At the interface between host and pathogen, extracellular
factors produced by pathogensare perfectly situatedto inﬂuence
the outcome of the interaction to the pathogen’s advantage.
Microbial pathogens possess an array of molecules that facilitate
adherence, invasion, inactivation of host defenses, and alteration
or destruction of host cells. Among the medically relevant fungal
pathogens, many of the demonstrated virulence factors are
extracellular, being either secreted into the surrounding milieu
or associated with the fungal cell wall. Shedding of surface
components, notably the Cryptococcus capsule component glu-
curonoxylomannan, Blastomyces Bad1, and Coccidioides SOWgp,
also aﬀect host cell function or the host immune system.
16-20
Underscoringthecentralroleofsecretedfactorsinpathogenesis,
many bacterial pathogens have evolved specialized secretion
systems for delivery of virulence eﬀectors into target host
cells.
21 In addition to the use of the general eukaryotic secretory
pathway,somefungireleaseprotein-containingvesiclesintotheir
surroundings providing an alternate mechanism to transport
proteins to the extracellular milieu.
22
Most of the factors identiﬁed to date that are necessary for
Histoplasma virulence are extracellular, either present on the
host-interacting pathogen surface or present in the soluble
culture ﬁltrate of yeast cells.
23 These molecules are prime
candidates for modifying the internal compartment in which
Histoplasma yeast reside following phagocytosis. Phagocytosis of
virulent Histoplasma yeast traﬃcs them to phagosomes in which
lumenacidiﬁcationisimpaired.Incontrast,phagocytosisofkilled
Histoplasmayeasttraﬃcsthemtoacidiﬁedphagosomalcompart-
ments and the yeast are digested by lysosomal enzymes.
24-26
ThissuggeststhatHistoplasmayeastactivelyproducefactorsthat
contribute to modiﬁcation of the yeast-containing phagosome,
survival of host defenses, and virulence. Despite this presumed
importance to Histoplasma pathogenesis, a clear deﬁnition of the
inclusive set of soluble extracellular components produced by
Histoplasma cells in the pathogenic yeast phase has not been
described.
In this project, we have identiﬁed the most abundant con-
stituents of the extracellular proteome of Histoplasma yeast.
Extracellular proteins were collected from culture ﬁltrates of
pathogenic yeast-phase Histoplasma cells. The protein identities
were ascertained through a shotgun mass spectrometry ap-
proach. Enriched expression of factors in the pathogenic phase
was determined by quantifying transcription of the encoding
genes by yeast cells versus nonpathogenic mycelia. To validate
therelevanceofthesecretedproteomedeﬁnitiontoinvivoyeast,
we conﬁrmed secreted protein expression by yeast cells during
residence in macrophages and during murine lung infection.
These ﬁndings provide an important framework on which
mechanistic studies of Histoplasma pathogenesis can be based,
speciﬁcally the role of extracellular yeast phase factors that could
inﬂuence the host-pathogen interaction.
’MATERIALS AND METHODS
Fungal Culture
TheclinicalisolateofHistoplasmacapsulatum,G186A(ATCC
26027) was the genetic background used for all studies. Strains
constructed from WU8, a ura5-deletion strain derived from
G186A, are presented in Table 1. Yeast- and mycelial-phase
cultures were grown in Histoplasma macrophage medium
(HMM
27)s u p p l e m e n t e dw i t h1 0 0μg/mL uracil. For maintenance
of the yeast phase, cultures were grown at 37 Cunder 5% CO2/
95%airwithshakingat200rpm.Mycelialculturesweregrownat
25-26Cinnormalair.Solidmediawaspreparedbyadditionof
0.6% agarose and 25 μM FeSO4. For infection studies requiring
uracilprototrophy, WU8 was transformedwithplasmid pCR473
carrying the URA5 gene. The growth phase of Histoplasma yeast
cultures was determined by treating aliquots of the culture with
1 M NaOH and measuring the optical density at 600 nm.
Culture Filtrate and Cellular Lysate Preparation
Replicate 200 mL yeast phase culture supernatants were
harvested fromcultures inmid-tolate-exponentialphase growth
(OD600nm=1.4to1.9).Cellsweregentlyremovedbyallowing
yeast to settle for 20 min followed by centrifugation at 1200g for
5 min to pellet residual yeast cells. Supernatants were sequen-
tially ﬁltered through 0.45 μm-pore and 0.21 μm-pore, mem-
branes (Millipore). Mycelial-phase culture ﬁltrates were
prepared by ﬁltration of mycelial cultures through Whatman #5
qualitative ﬁlter paper (approximately 2.5 μm-pore size) fol-
lowed by ﬁltration through a 0.21 μm-pore membrane. Culture
ﬁltrates were concentrated approximately 30-fold by ultraﬁltra-
tion through a 10 kDa molecular weight cut oﬀ polyethersulfone
membrane (Millipore) under 0.5 barr of pressure with gentle
stirring. The buﬀer was exchanged into 10 mM ammonium
acetate by dilution followed by ultraﬁltration. Cytoplasmic
proteins were prepared by beating yeast cells with 0.5 mm-
diameter glass beads in lysis buﬀer (50 mM Tris-HCl pH 7.5,
2mMEDTA,2mMDTT,50mMKCl,0.2%TritonX-100,with
1  protease inhibitor cocktail (Roche)). Protein concentrations
were determined by DC assay (Lowry-based; BioRad) using an
ovalbumin standard curve.
Electrophoretic Separation and Visualization of Proteins
Culture ﬁltrate proteins (6 μg) and yeast cellular lysates (3.5
μg) were denatured in reducing sample buﬀer (50 mM Tris pH
6.8,1%SDS,10%glycerol,and0.1MDTT),heatedfor10minat
100 C, and clariﬁed by centrifugation for 5 min at 16,000g.
Proteins were separated by electrophoresis through 10 and
12.5%NextGelpolyacrylamidegels(Amresco).Forvisualization
of separated proteins, gels were ﬁxed for 30 min at room
temperature in 40% ethanol/10% acetic acid, followed by silver
staining.
28,29 Silver stained images were captured with a Sony
ICX267 1.4 megapixel CCD camera with Alphaimager software
(Cell Biosciences).
Table 1. Histoplasma Strains
strain genotype other designation
G186A wild type (ATCC#26027)
WU8 ura5-Δ32 WT
a
WU29 ura5-Δ32 cbp1-Δ8::hph cbp1Δ
OSU17 ura5-Δ32/pCR473 [URA5, gfp-RNAi] gfp-RNAi
OSU52 ura5-Δ32/pEH15 [URA5, CATB-RNAi] CATB-RNAi
OSU62 ura5-Δ32/pEH11 [URA5, CFP1-RNAi] CFP1-RNAi
OSU63 ura5-Δ32/pEH09 [URA5, CFP4-RNAi] CFP4-RNAi
OSU64 ura5-Δ32/pCR438 [URA5, CFP8-RNAi] CFP8-RNAi
OSU66 ura5-Δ32/pBY08 [URA5, CATB:FLAG] CATB(þþþ)
aWU8 is the wild-type background except that the ura5 gene has been
deleted to allow transformation with URA5-based plasmids.1931 dx.doi.org/10.1021/pr1011697 |J. Proteome Res. 2011, 10, 1929–1943
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Shotgun Mass Spectrometry-Based Identification of Extra-
cellular Proteins
430 μg ofculture ﬁltrate sample were lyophilizedbyspeedvac.
Protein pellets were resuspended in 40 μL of Invitrosol
(Invitrogen) and heated at 100 C for 5 min followed by
60 C for 10 min with intermittent vortexing. The solution was
supplemented to a ﬁnal concentration of 25 mM ammonium
bicarbonate and 32.5 mM DTT. Reduced sulfhydryls were
blocked by addition of 80 mM iodoacetamide. The protein
solution was aliquoted into tubes with 8.1 μg of total protein.
For proteolytic digestion, trypsin (0.81 μg/μL; Sigma) or
chymotrypsin (0.91 μg/μL; Sigma) was added and reactions
incubated for 5 h at 37 C.
Total protein identiﬁcation was performed by capillary-liquid
chromatography-nanospraytandemmassspectrometry(Capillary-
LC-MS/MS) using a Thermo Finnigan LTQ orbitrap mass
spectrometer equipped with a nanospray source operated in
positive ion mode on 1 μg of digested culture ﬁltrate protein.
Samples were separated on a capillary column (0.2   150 mm
MagicC18AQ3μ200A,MichromBioresourcesInc.,Auburn,CA)
using UltiMate 3000 HPLC system from LC-Packings A Dionex
Co. (Sunnyvale, CA). Each sample was injected into the trapping
c o l u m na n dd e s a l t e dw i t h5 0m Ma c e t i ca c i df o r1 0m i nb e f o r e
injection onto the chromatography column. Mobile phase A was
0.1%formicacidinwaterandmobilephaseBwas0.1%formicacid
inacetonitrile.MobilephaseBwasincreasedfrom50%to90%over
5 min followed by holding at 90% for an additional 5 min before
being brought down to 2% in 1 min. MS/MS was acquired with a
nanospraysourceoperatedatasprayvoltageof2kVandacapillary
temperature of 175 C. The scan sequence of the mass spectro-
meter was based on the data-dependent TopTen method: the
analysiswasprogrammed for afullscanrecorded between400 and
2000 Da and a MS/MS scan to generate product ion spectra to
determine amino acid sequence in consecutive scans of the ten
most abundant peaks in the spectrum. The resolution of full
scan was set at 30000 to achieve high mass accuracy MS
determination. The CID fragmentation energy was set to 35%.
Dynamic exclusion was enabled with a repeat count of 30 s,
exclusion duration of 350 s. and a low and high mass width of
0.50 and 1.50 Da, respectively.
Sequence information from the MS/MS data was processed
by converting the Xcalibur (version 2.0) .raw ﬁles into a merged
ﬁle (.mgf) using ReAdW (version 4.3.1) and an in-house
program, RAW2MZXML_n_MGF_batch (merge.pl, a Perl
script). The resulting mgf ﬁles were searched using the MAS-
COT Daemon (Matrix Science, version 2.2.1) against an in-
house generated Histoplasma capsulatum genome database frag-
mented into 10 kb contigs which contained 5196 total database
entries.Thisdatabasewasconstructedfromthedraftassemblyof
the Histoplasma G186A genome (December 2004 assembly,
Washington University Genome Sequencing Center). The mass
accuracy of the precursor ions were set to 1.2 Da and the
fragment mass accuracy was set to 0.8 Da. Considered variable
modiﬁcations were methionine oxidation and carbamidomethyl
cysteine. Up to two missed cleavages for the enzyme were
permitted and peptides with a score less than 20 were removed.
Histoplasma contigs with a MASCOT score of 150 (for trypsin-
derived peptides) or 100 (for chymotrypsin-derived peptides)
wereselectedforfurtheranalysis(p<0.05).Falsediscoveryrates
were estimated using the MASCOT decoy feature, which
matches peptides against inverted database sequences and were
found to be 5, 9 and 7% for trypsin reactions and 6, 6 and 7% for
chymotrypsin reactions. Matching peptides were mapped to the
contig and were considered representative of a positive protein
identiﬁcationifatleasttwouniquepeptidesmatchedwithin1000
nucleotides of one another in the translated sequence and
matched amino acid sequences were encoded on the same
strand. Protein sequences were derived from a combination of
mass spectrometry-derived peptides, protein predictions (Broad
Institute), protein homologies, and manual alignment of encod-
ing exons with consensus splicing signals. To assign potential
functional descriptions, BLAST searches were performed using
the predicted protein sequence against identities in the non-
redundant NCBI protein database. The presence of N-terminal
secretion signals were identiﬁed using the SignalP algorithm
(version 3.0
30).
Identification of Proteins by Band Excision
Histoplasma yeast-phase culture ﬁltrate proteins (34 μg) were
separated by one-dimensional electrophoresis through a 10%
polyacrylamidegel.GelswerestainedeitherwithCoomassieblue
R-250orSYPRORuby(BioRad).Prominentproteinbandswere
excised using glass Pasteur pipets and acrylamide slices trans-
ferredtoasolutionof40%methanol/5%aceticacidandstoredat
4 C until peptide extraction. For peptide extraction, gel pieces
werewashedtwicein50%methanol/5%aceticacidforonehour,
and dehydrated in acetonitrile. Gel pieces were rehydrated and
incubatedwithDTTsolution (5mg/mLin100 mMammonium
bicarbonate) for 30 min before addition of iodoacetamide (15
mg/mL)for30min.Thegelplugswerewashedagainwithcycles
of acetonitrile and 100 mM ammonium bicarbonate in 5 min
increments. Gel plugs were dried in a speedvac, before the
addition of trypsin solution (20 μg/mL in 50 mM ammonium
bicarbonate) and overnight incubation at room temperature.
Peptides were extracted using 50% acetonitrile and 5% formic
acid several times and pooling the liquid. Extracted pools were
concentrated using speedvac.
Protein identiﬁcation was determined as above except mobile
phase A was water containing 50 mM acetic acid. A 5 cm/75 μm
IDProteoPepIIC18columnpackeddirectlyinthenanospraytip
was used for chromatographic separations. Peptides were eluted
directly oﬀ the column into the LTQ system using a gradient of
2-80% solvent B over 45 min, with a ﬂow rate of 300 nL/min.
Thetotalruntimewas65min.TheMS/MSwasacquiredusinga
nanospray source operated with a spray voltage of 3 kV and a
capillary temperature of 200 C. The CID fragmentation energy
was set to 35%. Dynamic exclusion was enabled with a repeat
count of 30 s, exclusion duration of 350 s. and a low and high
mass width of 0.50 and 1.50 Da, respectively. Peptide informa-
tion was used to search the Histoplasma 10 kb genome database
with the MASCOT daemon as described above.
Immunoblotting
Five to 36 μg of protein (either from yeast-phase culture
ﬁltrate or from yeast cellular lysates) were separated by electro-
phoresis through 10% polyacrylamide following denaturation
andproteinsweretransferredtoPVDFintransferbuﬀer(16mM
Tris base, 120 mM glycine, 0.05% SDS, and 20% methanol) at
4 C. For immunoblotting, the membrane was blocked with 5%
nonfat milk/0.05% Tween-20 followed by addition of anti-tubulin
antibody (Sigma B512). Detection was performed by incubation
with a horseradish peroxidase (HRP)-conjugated secondary
antibody and the Immobilon Western Chemiluminescent HRP
substrate (Millipore).1932 dx.doi.org/10.1021/pr1011697 |J. Proteome Res. 2011, 10, 1929–1943
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Histoplasma RNA Isolation and Analysis
Histoplasmayeastgrowntoexponentialphasewerecollectedby
centrifugation (2000g) and resuspended in TRIzol (Invitrogen).
Mycelia were collected from 8 day-old liquid cultures by ﬁltration
ontoWhatman#5ﬁlterpaperandscrapingoftheretainedmycelia
into TRIzol. Histoplasma RNA from infected macrophages was
obtained by infecting 6   10
6 P388D1 cells (a macrophage cell
linepermissiveforintramacrophageHistoplasmayeastgrowthand
replication) withHistoplasmayeastatamultiplicityofinfectionof
10 yeast to 1 macrophage in HMM-M (HMM buﬀered with
25mMsodiumbicarbonateinsteadof HEPES
31) containing 10%
fetal bovine serum. Cells and yeast were incubated at 37 C with
5%CO2/95% air for 40 h. Extracellular yeast were removed by
extensive washing with PBS, and P388D1 cells were lysed by a
hypotonic solution of 10 mM Tris pH 8.0. The liberated yeast
were collected from the macrophage lysate by centrifugation and
resuspendedinTRIzol.ToisolateHistoplasmaRNAfrominfected
mouse lungs, ten C57BL/6 mice (Harlan) were intranasally
infected with 1   10
7 yeast per mouse. After 24 h, lungs were
removed and homogenized in hypotonic 10 mM Tris, 1 mM
EDTA buﬀer to free yeast from mammalian tissue. Homogenates
were pooled together and debris removed by passing through
sterile gauze using a Buchner funnel. Yeast and mammalian
nuclei were collected by centrifugation (3000g for 5 min) and
resuspended in 6 mL of TRIzol. To reduce viscosity, the suspen-
sion was passed through a 21 gauge needle. Yeast were collected
again by centrifugation and washed 4 times in TRIzol before
isolating RNA.
RNAwasliberatedfromHistoplasmacellsinTRIzolbybeating
with 0.5 mm-diameter glass beads. RNA was puriﬁed by extrac-
tionwithCHCl3followedbyalcoholprecipitationoftheaqueous
phase. Genomic DNA was removed by two sequential digestions
with Turbofree DNase (Ambion) and lack of genomic DNA
veriﬁed by PCR. Reverse transcription was performed using
Superscript III reverse transcriptase (Invitrogen) using 5 μgo f
total RNA and random 15-mer or oligo dT 22-mer primers.
End point PCR ampliﬁcation of candidate genes was per-
formed using gene speciﬁc primers with random 15-mer primed
reverse-transcribedRNAtemplates. Ampliﬁcationreactionscon-
tained 1:200 reverse-transcribed RNA templates, 0.5 μM of each
primer, and 150 μM dNTPs. For ampliﬁcation, 35 cycles
(intramacrophage RNA samples) or 45 cycles (RNA from
infected lungs) were performed with the following parameters:
94 C for 10 s, 55 C for 15 s, 72 C for 1 min. PCR amplicons
were detected by 1.5% agarose gel electrophoresis. Control
reactions using nonreverse transcribed RNA veriﬁed ampliﬁed
products were derived from transcripts and not genomic DNA
contamination.
Quantitative PCR was performed on reverse-transcribed RNAs
from three biological replicate cultures of yeast and mycelia. Reac-
tions were assembled using a SYBR-green based PCR master mix
(BioRad) with diluted reverse-transcribed templates (1:200 ﬁnal)
and 0.5 μM each gene speciﬁc primer. Cycling was performed with
anIQ5thermocycler(BioRad)usingthefollowingconditions:95C
for8minfollowedby50cyclesof95Cfor10s,55Cfor15s,72C
for 1 min. Relative transcript enrichment in yeast was determined by
comparing the Ct values from yeast and mycelia using the ΔΔCt
method
32 after normalizing to levels of the RPS15 transcript.
Construction of RNAi Lines
Plasmids for RNAi-mediated depletion of candidate factors
were created by insertion of duplicate copies of the target gene
sequence in inverted orientation into a URA5(þ)H i s t o p l a s m a
RNAi vector as described.
15 Eight-hundred to 1000 base pairs
of target gene sequence were ampliﬁed by PCR from Histo-
plasma reverse-transcribed RNA. Primers for ampliﬁcation
were designed with restriction sites to facilitate cloning of the
fragments intothe RNAi vector (primer sequences available on
request).
RNAi constructs were introduced into WU8 Histoplasma
yeast by electroporation of 200 ng of PacI-linearized plasmid
DNA.
33TransformedyeastwereplatedonHMMplatestoselect
for uracil prototrophs. Transformants were used to inoculate
liquid HMM cultures, which were grown at 37 C to late
exponential phase. Cell-free culture supernatants were collected
from each and the proteins separated by SDS-PAGE. Protein
loadingswerenormalizedtoculturedensityasdeterminedbythe
optical density of cultures at 600 nm. When necessary, super-
natants were deglycosylated ﬁrst using PNGase F according to
the manufacturer’s protocol (New England Biolabs). Gels were
silver stained as previously described to visualize extracellular
proteins.
’RESULTS
Characterization of the Histoplasma Extracellular Protein
Profile
To identify the proteinaceous extracellular factors produced
by Histoplasma, we collected culture ﬁltrates from Histoplasma
grown in the pathogenic-phase. Histoplasma strain G186A, a
clinical strain from the Panamanian phylogenetic group, was
selected for these studies because (i) it is representative of
chemotype II strains which comprise ﬁve of the six phylogeneti-
cally distinguishable Histoplasma lineages found worldwide,
34
(ii) G186A is well established as a virulent isolate, (iii) suﬃcient
genome nucleotide sequence coverage exists to enable proteo-
mic-based analyses. In addition, the G186A strain is the most
genetically tractable of laboratory Histoplasma strains: it is easily
transformed, ura5 auxotroph backgrounds exist that allow selec-
tion of URA5-based plasmids, and gene knock-downs and
knockouts can be generated to facilitate validation of protein
identities through molecular genetics.
Asourprimaryinterestisinextracellularfactorswithrelevance
to Histoplasma pathogenesis, we focused on those culture ﬁltrate
proteins produced by Histoplasma yeast as compared to those of
Histoplasma grown as nonpathogenic mycelia. To approximate
the in vivo growth condition, Histoplasma yeast were cultured in
liquid Histoplasma-macrophage medium (HMM), a tissue-cul-
ture based medium that supports the growth and replication of
Histoplasma yeast cells when cocultured with macrophages.
31
Culturesweremaintainedaspathogenic-phaseyeastbygrowthat
37 C under 5% CO2/95% air. Following concentration of the
cultureﬁltrate,proteinswereseparatedbyone-dimensionalSDS-
PAGE and visualized by silver staining (Figure 1A). Since the
already identiﬁed 8-11 kDa Cbp1 virulence factor is extremely
abundant in culture ﬁltrates and it could potentially saturate
downstream protein identiﬁcation procedures, we used for our
proteomic analyses Histoplasma strain WU29, a strain derived
from G186A in which the CBP1 gene has been deleted (cbp1Δ).
With the obvious exception of the Cbp1 protein, yeast-phase
supernatants prepared from three replicate cbp1Δ cultures look
identical to that derived from the wild-type G186A strain
(Figure 1A). To determine the degree of uniqueness of the
proteins released by pathogenic-phase Histoplasma, yeast-phase1933 dx.doi.org/10.1021/pr1011697 |J. Proteome Res. 2011, 10, 1929–1943
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culture ﬁltrate proteins were compared to the proteins secreted
by mycelia as well as intracellular yeast proteins. By one-dimen-
sional separation, the detectable yeast-phase proteins were
markedly distinct from the major proteins recovered from
mycelial-phase culture ﬁltrates as well as the majority of
intracellular yeast-phase proteins (Figure 1A). Noticeably,
yeast-phase culture ﬁltrates are characterized by a prominent
highmolecularweightsmearconsistentwithheavilyglycosylated
proteins.Ourattemptsattwo-dimensionalseparationofproteins
proved unsuccessful, possibly due to the high degree of protein
glycosylation or abundant release of polysaccharides that inter-
fere with isoelectric focusing.
Since the validity of any extracellular proteome deﬁnition
depends on the fraction purity, we veriﬁed that our pathogenic-
phase culture ﬁltrate preparations were obtained from cultures
with no signiﬁcant cellular lysis. As indicators of cytosolic
contamination (e.g., through lysis of yeast cells during culture
or during harvesting of the supernatants), we tested the samples
for the presence of R-tubulin by immunoblotting, for Histoplas-
ma DNA using PCR, and for the cytosolic enzyme homogenti-
sate dioxygenase by enzymatic assay. Whereas the R-tubulin
protein is readily detected in cellular lysates, no R-tubulin was
detectable in the culture ﬁltrates indicating little contamination
of the culture ﬁltrate by cellular antigens (Figure 1B). Similarly,
no Histoplasma DNA was detected in culture ﬁltrates by PCR
(Supplemental Figure 1A, Supporting Information). While cel-
lular lysates have signiﬁcant homogentisate dioxygenase activity,
culture ﬁltrate samples lack any detectable dioxygenase activity,
even when 16-fold greater volume of culture ﬁltrate volume is
assayed compared to the cytosolic lysate (Supplemental Figure
1B, Supporting Information). Thus, the isolated culture ﬁltrates
reﬂect the extracellular population of factors.
We also veriﬁed that our culture ﬁltrate isolation and con-
centration procedures did not alter the protein composition of
the yeast-phase culture ﬁltrate. To check for loss of protein due
to natural extracellular protease activity, we compared culture
ﬁltrates collected in the presence or absence of protease
inhibitors.Nosigniﬁcantreductioninproteinamountorchange
in one-dimensional electrophoretic proﬁle was observed
(Supplemental Figure 2, Supporting Information). To prepare
samples for mass spectrometry, proteins were concentrated by
ultraﬁltration and lyophilization and recovered by resuspension
in Invitrosol buﬀer. Comparison of protein samples before and
after lyophilization and resuspension showed that 92% of the
proteinwasrecoveredandthattheﬁnalproteincompositionwas
indistinguishablefromtheoriginalcultureﬁltratesamplebyone-
dimensional gel electrophoresis (Supplemental Figure 2, Sup-
porting Information).
Identification of the Major Constituents of the Pathogenic-
Phase Extracellular Proteome
Since the major extracellular factors of pathogenic phase cells
areclearlydistinctfromthoseproducedbythemycelialphase,we
employed a shotgun mass spectrometry approach to identify
those proteins that comprise the pathogenic phase extracellular
proteome. Culture ﬁltrates were concentrated by ultraﬁltration
and subjected to proteolytic digestion. Peptide sequences were
extrapolated from the peptide masses obtained through mass
spectrometry. Genomic DNA sequence from strain G186A was
searchedusingtheMASCOTalgorithm
35toidentifytheputative
secreted protein-encoding genes. Limiting our searches to the
catalog of Histoplasma predicted genes would be only as success-
ful as the reliability of those predictions (which are based largely
on gene homologies and hypothetical genes from other fungal
genomes). To make our searches less biased toward predicted
genes and their products, we instead searched the obtained
peptide sequences against the translated genome sequence.
Figure 1. Protein proﬁles of Histoplasma cellular and extracellular
fractions. (A) Histoplasma culture ﬁltrate (CF) proteins from yeast-
phase (Y-phase), mycelial-phase (M-phase), and a yeast-phase cellular
lysate were separated by one-dimensional SDS-PAGE (10% NextGel)
andvisualizedbysilverstaining.Threeindependentcultureﬁltratesfrom
cbp1Δ yeast were compared for biological reproducibility and only
lacked the 8-10 kDa Cbp1 protein present in wild type (WT) yeast-
phase culture ﬁltrates. (B) R-Tubulin immunoblot of Histoplasma
culture ﬁltrates show lack of detectable cytosolic contamination. Eigh-
teenor36μgofconcentratedyeast-phasecultureﬁltrateor5or10μgof
yeast cellular lysate were probed with an antibody to the cytosolic
protein R-tubulin following transfer to PVDF.1934 dx.doi.org/10.1021/pr1011697 |J. Proteome Res. 2011, 10, 1929–1943
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Reasoningthatmostprotein-codinggenesarelessthan10kb,we
fragmented the G186A genome sequence into 10 kb length
contigsthatoverlapby1000basepairsandusedthis10kbcontig
database as the subject for our MASCOT searches. As the
MASCOT algorithm interprets each 10 kb contig as a single
candidate sequence, raw MASCOT scores can be artiﬁcially
inﬂated due to multiple peptides matching the contig yet not
corresponding to the same protein. Consequently we used the
MASCOT scores only as a preliminary estimate of peptide
matching and considered a score of 100 as an initial cut oﬀ to
direct our manual inspection of peptide matches. Peptides were
assigned to the same protein if their sequences (1) matched
within the same 10 kb contig, (2) were encoded on the same
DNA strand, and (3) were no greater than 1000 base pairs from
another peptide match on a given contig.
To provide greater conﬁdence in the protein identiﬁcations
obtained through mass spectrometry, we analyzed multiple
pathogenic-phase culture ﬁltrates and employed proteases with
dissimilar cleavage sites. We used three biological replicate
samples as an indicator of variability in protein secretion. We
obtained 5741total peptidesfrom thethree samples(2470 total
peptides for sample 1, 1345 total peptides for sample 2, and
1926 total peptides for sample 3). As shown in Figure 2A, the
protein proﬁles represented by the peptides from the three
replicates showed some diﬀerences. Nevertheless, the peptides
corresponding to proteins in at least two of the three culture
ﬁltrate samples account for over 90% of the total peptides
isolated; 547 of the 5741 peptides match proteins present in
only a single sample. To guard against false positive identities,
each sample was digested separately with trypsin as well as with
chymotrypsin to generate a population of diﬀerent proteolytic
fragments representing the same extracellular proteins. We
consideredaspositiveproteinidentiﬁcation,onlythoseproteins
deﬁned by peptides derived from both trypsin digestion as well
as from chymotrypsin. In addition, only proteins deﬁned by at
least two unique peptides and present in all three culture ﬁltrate
samples constituted the ﬁnal census of extracellular proteins
(Table 2). These criteria identiﬁed 33 proteins which were
represented by over 70% of the total peptides obtained
(Figure 2A). By consideration of consensus splicing signals
and protein homologies, we mapped the obtained peptides to
the conceptually translated nucleotide sequence for each of
these proteins. Peptide coverage for the extracellular proteins
fell between 15 and 87% (Table 2). Not all predicted peptide
sequences from a given protein were recovered likely due to
peptide mass-altering post-translational modiﬁcations (e.g.,
glycosylation) or peptides whose nucleotide coding sequence
spanned exon-exon junctions.
Theidentiﬁedproteins were classiﬁed as to potential function
using homology to other eukaryotic proteins (Figure 2B,
Table 2). Six proteins had glycosidase or glycosyl transferase
domains with two predicted to function as glucanases (Exg1 and
Eng1) and one as a chitinase (Chs1). Given that the yeast cell
wall is comprised of glucan and chitin polymers, these proteins
were designated as polysaccharide/cell wall associated. Five of
the proteins showed no signiﬁcant homologies to proteins with
known functions and were designated as culture ﬁltrate proteins
(Cfp’s).Basedongenepredictions,otherfungalgenomesappear
toencodeproteinshomologoustotheHistoplasmaCfpproteins.
Three proteins linked to oxidative stress (catalase B, CatB;
superoxide dismutase, Sod3; and a thioredoxin reductase-like
protein designated as Trl1) were found in the culture
supernatant. CatB and Sod3 represent distinct enzymes from
those involved in detoxiﬁcation of intracellular reactive oxygen
compounds (Supplemental Figure 3, Supporting Information).
The set of extracellular proteins also included ﬁve with chaper-
one-like functions including protein disulﬁde isomerase (Pdi1),
peptidyl-prolyl cis-trans isomerase D (Fpr2), and three pro-
teins with homology to heat shock factors (Hsp60, Hsp82, and
Ssa1). The extracellular proteome had four dehydrogenase
enzymes with predicted speciﬁcities for glutamate (Gdh1),
mannitol phosphate (Mpd1), dihydrolipoamide (Lpd1), and
homoserine (Hom1). Despite the validated lack of signiﬁcant
cytosolic contamination of our samples, ten normally cytosolic
proteinswerepresentintheextracellularproteomeandincluded
metabolic enzymes, peptidases, and other normally cytosolic
proteins. Using the number of peptides as an approximate
indicator of abundance, the ﬁve major protein classes represent
84% of the peptides identiﬁed from the extracellular proteome
(Figure 2B). Database accession numbers for these 33 extra-
cellular proteins are providedinSupplemental Table1, Support-
ing Information.
Secreted proteins typically possess a secretion signal, often a
hydrophobic stretch of amino acids at the N-terminus of the
proteinfollowedbyacleavagesite,whichtargetstheproteininto
the eukaryotic secretory pathway. We used the Signal P algorithm
30
to determine the likelihood that each extracellular protein
possessed a secretion signal. While not all secreted proteins have
canonical signal peptides, 14 of the 33 Histoplasma extracellular
proteins contained a likely N-terminal secretion signal (Mean S
score > 0.7; Table 2). In particular, all of the proteins from the
polysaccharide/cell wall class, all proteins with unknown func-
tions, and all proteins involved in reactive oxygen stress defense
had readily discernible signal sequences. Although the predicted
signal sequences have not been functionally validated, they are
consistent with the presence of these 14 proteins in the experi-
mentally derived extracellular protein fraction and lend support
to their extracellular localization. Additionally, no peptides
corresponding to these putative signal sequences of extracellular
proteinswererecoveredconsistentwithproteolyticprocessingof
the sequences during transit through the secretory pathway.
In addition to identiﬁcation of extracellular proteins by the
shotgun approach, we isolated yeast-phase protein bands from
one-dimensional SDS-PAGE gels and subjected them to mass
spectrometry after trypsin digestion. Peptides derived from the
masses obtained were aligned to the Histoplasma translated
genome sequence with MASCOT. The protein identities ob-
tained through this process matched those constituents of the
extracellular proteome deﬁned by shotgun mass spectrometry,
providing further validation of the ascertained protein identities.
For ten of the prominent bands of electrophoretically separated
culture ﬁltrate proteins, the vast majority of tryptic peptides
deﬁned an individual extracellular antigen (Figure 3). Multiple
extracellular proteins were found in the slowly migrating protein
smearbetween100and200kDaandincludedChs1,Eng1,Cfp4,
and Aps1.
ExpressionofExtracellularProteinsinthePathogenicPhase
SincethedimorphismofHistoplasmareﬂectsadevelopmental
switch to the yeast-phase regulon that is necessary for virulence,
we examined the relative expression of secreted protein-encod-
ing genes by Histoplasma cells growing as pathogenic yeast
compared to growth as nonpathogenic mycelia. The genes that
speciﬁcally characterize the yeast-phase regulon constitute1935 dx.doi.org/10.1021/pr1011697 |J. Proteome Res. 2011, 10, 1929–1943
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probable candidate factors that promote Histoplasma virulence.
To determine the degree of yeast-phase speciﬁcity, quantitative
reverse-transcription PCR (qRT-PCR) was used to assess the
levels of transcription by yeast-phase cells and by mycelia. Total
RNA was isolated from wild-type G186A Histoplasma cells
incubated at 37 C (yeast) or from cells incubated at 25 C
(mycelia). Three independent RNA populations were prepared
from yeast-phase and mycelial-phase cultures and reverse tran-
scription of the RNAs was primed with oligo-dT and random
15-mer primers. To ensurethatPCR targetedgenuinetranscript
sequences, we designed quantitative PCR primers to nucleotide
regions forwhichcorrespondingpeptides hadbeenidentiﬁed by
mass spectrometry. Individual transcript levels were normalized
to expression of the small ribosomal subunit gene RPS15 which
shows equivalent expression in both phases (data not shown).
The speciﬁcity for the pathogenic phase was determined by
comparison of the relative levels of yeast-phase versus mycelial-
phase expression of each secreted protein encoding gene.
Figure 2. Proteomic identiﬁcation of the major constituents of the extracellular proteome of Histoplasma yeast. (A) Venn diagram comparing the
proteins present in three independent yeast-phase culture ﬁltrates shows 33 factors common to all three samples. (B) Chart depicts the classiﬁcation of
extracellular protein identities and indicates their approximate abundance based on the number of peptides obtained. Protein identities having
N-terminal signal sequences (as determined by Signal P 3.0) are indicated in bold type. Proteins in the ﬁve major classes constitute 84% of the total
peptides in the extracellular proteome. Protein identities were determined by LC-MS/MS of trypsin- and chymotrypsin-digested culture ﬁltrate
samples.1936 dx.doi.org/10.1021/pr1011697 |J. Proteome Res. 2011, 10, 1929–1943
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Expressionanalysisrevealed10extracellular-protein encoding
genes with signiﬁcant upregulation during pathogenic-phase
growth (Figure 4). The yeast-phase speciﬁc gene CBP1 showed
over 4000-fold enrichment in yeast as compared to mycelia. The
level of MS8 mRNA, a transcript known to be enriched in
mycelia,
36 was 20-25 fold higher in mycelia. These results
conﬁrm the purity of the yeast and mycelia cultures from which
RNAs were isolated. We classiﬁed as yeast-phase “speciﬁc” and
yeast-phase “enriched” transcripts those showing at least 80-fold
or at least 5-fold higher expression in the yeast phase, respec-
tively. Of the genes encoding secreted proteins with unknown
functions, CFP4 showed strong speciﬁcity for the yeast-phase. In
particular,CFP4transcriptionisessentiallyexclusivetotheyeast-
phase; CFP4 mRNA is over 19,000-fold higher in yeast as
compared to mycelia and CFP4 mRNA was not detected in
mycelia-phase RNAs by end point RT-PCR (data not shown).
Other yeast-phase speciﬁc transcripts include genes for the
extracellular endoglucanase (ENG1) and chitinase (CHS1).
Transcription of both the extracellular catalase (CATB) and
superoxide dismutase (SOD3) genes were substantially higher
(approximately 100-fold) in yeast-phase cells than in mycelia.
The genes encoding Cfp1, Cfp7, and Cfp8, as well as the
extracellularexoglucanase(Exg1),andthioredoxinreductaselike
factor (Trl1), while not as unique to the yeast-phase, were
nonetheless expressed signiﬁcantly higher by yeast-phase cells
than mycelia. The genes encoding the remaining glucosidases
(BGL1, GEL3, GEL4), and other proteins of unknown function
showed no particular enrichment for the yeast-phase. While the
chaperone-like proteins Pdi1, Hsp82, and Ssa1, are components
of the yeast-phase extracellular proteome, their transcription is
similarbetweenpathogenic andnonpathogenicphases. Onlythe
aminopeptidase genes APS1 and APS2 were more abundantly
transcribed by mycelia than by yeast cells. The connection
between yeast and Histoplasma pathogenicity focused our atten-
tion on the 10 factors whose transcripts are particularly enriched
in the pathogenic-phase (i.e., Cfp1, Cfp8, Cfp4, Cfp7, Exg1,
Eng1, Chs1, CatB, Sod3, and Trl1). Notably, these 10 proteins
are represented by 58% of the peptides deﬁning the extracellular
proteomeandeachispredictedtopossessaN-terminalsecretion
signal.
Table 2. Components of the Histoplasma Pathogenic-Phase Extracellular Proteome
protein % coverage total peptides secretion signal score
a total trypsin-derived peptides
b total chymotrypsin-derived peptides
b putative function or homology
CatB 73 439 0.869 179(25) 168(23) catalase B
Eng1 80 412 0.851 180(25) 188(32) endo-(1,3)-β-glucanase
Chs1 57 345 0.949 142(16) 154(18) chitinase
Pdi1 54 242 0.266 117(15) 114(14) protein disulﬁde isomerase
Cfp1 79 229 0.933 72(9) 119(14) Aspergillus allergen Asp f4
Cfp8 81 177 0.872 49(10) 82(10) (novel)
Exg1 48 177 0.941 72(13) 91(16) exo-(1,3)-β-glucanase
Fpr2 55 170 0.197 117(10) 42(11) peptidyl-prolyl cis-trans isomerase
Cfp7 61 167 0.785 65(11) 82(13) SUN-domain containing protein
Gel3 59 149 0.844 76(10) 66(12) β-(1,3)-glucanosyltransferase
Mpd1 86 147 0.142 94(17) 53(14) mannitol-phosphate dehydrogenase
Gdh1 75 141 0.041 56(18) 29(10) glutamate dehydrogenase
Lpd1 62 140 0.341 99(19) 41(10) dihydrolipoamide dehydrogenase
Cfp4 50 133 0.901 21(4) 82(8) (novel)
Cit1 54 131 0.233 54(13) 57(13) methylcitrate synthase
Hsp82 48 126 0.093 87(19) 31(11) heat shock cognate molecule
Cfp11 44 124 0.702 71(12) 46(10) (novel)
Hsp60 53 112 0.262 93(19) 19(6) heat shock protein 60
Gel4 48 106 0.726 29(6) 75(14) β-(1,3)-glucanosyltransferase
Aps1 28 100 0.186 66(15) 28(8) amino peptidase
Rad24 78 97 0.106 64(8) 33(6) DNA-damage checkpoint protein
Eﬀ1b 66 75 0.073 33(7) 42(8) elongation factor 1β
Bgl1 45 72 0.840 26(5) 33(8) β-glucosidase
Eno1 51 68 0.068 51(8) 17(7) enolase
Pgk1 44 65 0.034 37(13) 28(8) phosphoglycerate kinase
Ssa1 15 59 0.135 29(2) 30(5) HSP70-like protein
Tgc1 42 55 0.027 33(5) 22(3) telomeric ssDNA-binding protein
Trl1 87 54 0.975 25(5) 29(8) thioredoxin reductase-like protein
Sba1 53 51 0.083 32(4) 21(5) P21 cell-cycle regulator
Rpp2 42 49 0.134 22(3) 27(3) 60S ribosomal protein 2
Ipp1 24 36 0.375 19(3) 17(4) inorganic pyrophosphatase
Hom1 38 35 0.497 13(5) 22(5) homoserine dehydrogenase
Sod3 22 25 0.820 18(2) 7(2) Cu/Zn superoxide dismutase
aSecretion signal scores (mean S-score) determined by the Signal P algorithm.
bTotal peptide number with the number of unique peptides given in
parentheses.1937 dx.doi.org/10.1021/pr1011697 |J. Proteome Res. 2011, 10, 1929–1943
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Molecular Genetic Confirmation of Pathogenic-Phase
Extracellular Protein Identities
Since extracellular proteins were identiﬁed through peptide
masses, we validated the deduced nucleotide coding sequence
through molecular genetic-based depletion of target proteins
(Figure 5). The ineﬃciency of homologous recombination in
Histoplasma led us to use RNA interference (RNAi) to deplete
target proteins. RNAi silences protein production based on
nucleotide sequence identity with a targeted transcript. This
provides important conﬁrmation of novel proteins whose pre-
dicted gene structure could not be supported by homology to
knownproteinsinpublicdatabases.Weselectedastargets,yeast-
phase enriched factors for which we could monitor protein
depletion by one-dimensional electrophoretic separation of
culture ﬁltrate proteins. RNAi vectors targeting the yeast-phase
enriched factors Cfp1 and Cfp8 and the yeast-phase speciﬁc
protein Cfp4 were constructed based on the predicted encoding
gene sequences, and vectors were transformed into Histoplasma
yeast. In the absence of available antibodies to these extracellular
factors to monitor protein loss, we screened concentrated yeast-
phase culture ﬁltrates for loss of speciﬁc protein bands. Histo-
plasma transformants were grown in liquid HMM as yeast (i.e.,
cultured at 37 C), the cell free culture supernatants collected,
and the extracellular proteins separated by one-dimensional
SDS-PAGE and visualized by silver staining. Culture ﬁltrates
fromyeasttransformantsharboringeithertheCFP8-RNAiorthe
CFP1-RNAi vector showed loss of a single 29 kDa protein band
or 26 kDa protein band, respectively when compared to the
extracellularproteinproﬁleofwildtypeyeast(Figure5A).RNAi-
baseddeterminationoftheseproteinbandidentitiescorresponds
to their predicted molecular weight and matches their identiﬁca-
tion as Cfp8 and Cfp1 obtained through band excision and mass
spectrometry (Figure 3).
The molecular weight based on the amino acid sequence of
Cfp4 is 23 kDa, but this is inconsistent with its presence in the
slower mobility smear as determined by band excision. This
suggests that Cfp4 might be highly glycosylated. To test this
possibility, N-linked glycans were removed from extracellular
proteins by digestion of culture ﬁltrates with PNGase F, and the
resultant deglycosylated proteins were separated by one-dimen-
sional SDS-PAGE (Figure 5B). After N-linked deglycosylation,
the slowly migrating smear largely disappears and a prominent
protein band is detected around 38 kDa (compare Figure 5B to
Figure 3). This approximate 38 kDa protein is absent in
deglycosylated culture ﬁltrates prepared from two separate
CFP4-RNAi lines of Histoplasma yeast (Figure 5B) identifying
thebandasCfp4.Thestilllargerapparentmolecularweightfrom
that predicted may represent additional O-linked glycosylation
which would not be removed by PNGase F and would retard its
electrophoretic mobility. This result conﬁrms the identity of
Cfp4 as a member of the extracellular proteome and demon-
strates the protein is substantially modiﬁed through N-linked
glycosylation.
RNA interference was also used to validate the presence of
catalase B in the extracellular pathogenic-phase proteome. En-
zymatic analysis shows wild-type culture ﬁltrates possess catalase
activity consistent with the presence of secreted CatB (data not
shown). We created an RNAi vector that speciﬁcally targets the
CATB gene sequence and transformed it into Histoplasma yeast.
Separation and visualization of the extracellular proteins har-
vested from CATB-RNAi yeast cultures showed a conspicuous
deﬁciency of a 90 kDa band when compared to wild type culture
ﬁltrates (Figure 5C). As a secondary conﬁrmation of this protein
band as CatB, we constructed a vector in which transcription of
CATB was initiated from a strong constitutive promoter and
examined culture ﬁltrates from Histoplasma yeast transformed
with this overexpression vector for increased abundance of a
speciﬁc protein. Consistent with the band identiﬁed as CatB
through RNAi, overexpression of CatB led to a prominent
increase in this same 90 kDa band (Figure 5C).
We also used RNAi to deplete Gdh1 from yeast-phase culture
ﬁltrates. Although this protein was not one of the yeast-phase
enriched or yeast-phase speciﬁc proteins, Gdh1 was consistently
found in culture ﬁltrates and the protein was associated with a
particular band by one-dimensional gel electrophoresis of extra-
cellular proteins. Culture ﬁltrates from yeast carrying an RNAi
vector targeting Gdh1 are speciﬁcally depleted of the Gdh1
protein band following one-dimensional electrophoresis (data
not shown). We also conﬁrmed the depletion of Gdh1 by
enzymatic assay; culture ﬁltrates from two independent GDH1-
RNAi lines show at least 3-fold reduction in extracellular
glutamate dehydrogenase activity compared to GDH1(þ) cul-
ture ﬁltrates (data not shown).
Confirmation that Pathogenic-Phase Extracellular Factors
Are Expressed during Infection
The proteomic analyses described above identiﬁed the extra-
cellular proteins released by Histoplasma yeast grown in liquid
culture and not directly from host environments. While in vitro
Figure 3. Conﬁrmation of protein identities by protein excision from
SDS-PAGE and LC-MS/MS. Thirty-four micrograms of yeast-phase
culture ﬁltrate were separated by one-dimensional SDS-PAGE and
individual protein bands excised and subjected to LC-MS/MS analysis
to determine protein identities. The principal protein isolated in each
band is indicated by the protein designation adjacent to the respective
band.Proteinspresentintheuppermolecularweightsmearareincluded
as a group since protein bands could not be individually resolved.1938 dx.doi.org/10.1021/pr1011697 |J. Proteome Res. 2011, 10, 1929–1943
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culture was necessary to harvest enough material for mass
spectrometry, eﬀorts were made to approximate the environ-
ment that would be encountered by yeast within the mammalian
host.Toconﬁrmthattheextracellularfactorsproducedinculture
are produced by Histoplasma yeast during residence within
phagocytic cells, we examined the transcription of candidate
protein-encoding genes by yeast during infection of cultured
macrophages (Figure 6). Macrophages were infected with His-
toplasma yeast for 40 h and internalization and intramacrophage
residence of yeast was veriﬁed by microscopy. RNA was isolated
fromthecocultureandRT-PCRwasperformedusingprimersfor
the genes encoding each of the yeast-phase speciﬁc and yeast-
phaseenrichedfactors.Allprimersetsampliﬁedspeciﬁcproducts
from Histoplasma genomic DNA, and with the exception of the
mycelial-phase transcript MS8, all genes were expressed by
Histoplasma yeast grown in laboratory culture. We detected
transcripts corresponding to each of the pathogenic-phase extra-
cellular factors from RNA isolated from yeast resident within
macrophages conﬁrming these factors are expressed by intrama-
crophage Histoplasma yeast. No amplicons were produced from
intramacrophage yeast RNA in the absence of reverse transcrip-
tion (data not shown) nor from uninfected macrophage RNA.
To determine if Histoplasma yeast express constituents of the
pathogenic-phase extracellular proteome in vivo, we examined
transcription of the candidate genes by yeast during respiratory
infection of mice. Mice were infected intranasally with wild-type
Histoplasmayeastandlungswereremovedafter24hofinfection.
Histoplasma yeast were recovered from infected lung tissue
and RNA was isolated. RT-PCR was performed using primers
for genes encoding the yeast-phase speciﬁc and yeast-phase
enriched proteins after reverse-transcription primed by random
nucleotide oligomers (Figure 6). In RNA harvested from yeast
isolated from infected lungs, mRNA was detected for the house-
keeping gene RPS15 as indicated by the faster migrating ampli-
con corresponding to the spliced RPS15 transcript. In the
absence of reverse transcription, no amplicons were produced
from yeast RNA from infected lungs (data not shown) nor were
amplicons produced from reverse-transcribed RNA harvested
from uninfected lungs (Figure 6). Similar to our results from
intramacrophage yeast, yeast-phase speciﬁc and yeast-phase
enriched factors were detected in RNA from yeast isolated
directly from infected lungs. This data establishes the validity
of the in vitro-derived extracellular proteome of pathogenic-
phase Histoplasma to yeast infecting the mammalian host.
’DISCUSSION
The success of Histoplasma as an intracellular pathogen
depends on avoidance or neutralization of the defense mechan-
isms of the host macrophage. In this study, we identiﬁed the
primary constituents of the Histoplasma pathogenic phase extra-
cellular proteome as a foundation upon which to base studies to
deﬁne the factors that inﬂuence the outcome of the host-
pathogen interaction. In addition, exoantigens represent attrac-
tive molecules for antigenemia-based diagnostic tests. For ex-
ample, the H- and M-antigens of Histoplasma are culture ﬁltrate
molecules β-glucosidase and catalase, respectively.
37-39 Current
diagnosisofdisseminatedhistoplasmosisutilizesanELISA-based
assay for an extracellular polysaccharide antigen.
40 While the
proteome assembled here identiﬁes constituents in the cell-
free supernatant, we do not distinguish between those soluble
components which are not associated with the yeast cell surface
Figure 4. Relative expression of extracellular protein-encoding genes by yeast or mycelial-phase Histoplasma cells. Quantitative RT-PCR of RNA
isolated from wild-type Histoplasma yeast and mycelial cultures shows ten proteins are enriched in yeast phase cells. Cultures were grown at 37 C for
yeastor25Cformyceliacultures.Gene-speciﬁcprimerswereusedforeachreactionandthefold-changeintranscriptlevelscalculatedusingtheΔΔCT
method after normalizing to the ribosomal RPS15 gene. Bars represent the average of three biological replicates and error bars indicate the standard
deviation. The fold change in expression (yeast relative to mycelia) for proteins with at least a 5-fold change (dotted line) is indicated above the
respective bars.1939 dx.doi.org/10.1021/pr1011697 |J. Proteome Res. 2011, 10, 1929–1943
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andthosesurface-associatedmoleculeswhichcouldbeshedfrom
the yeast cell as has been found for Yps3.
41
Our studies focused on yeast-phase proteins since virulence is
precisely linked to this state. Factors preferentially produced by
Histoplasma yeast will thus likely be tailored to beneﬁt the
pathogenic lifestyle unique to this phase. Indeed, one-third of
the major constituents of the extracellular proteome are ex-
pressed exclusively by cells in the pathogenic phase or are
signiﬁcantly enriched compared to cells in the nonpathogenic
phase. This pattern mirrors the phase-speciﬁc production of
three of the known virulence factors identiﬁed to date: secreted
Cbp1,
42 cell wall R-glucan,
43,44 and Yps3.
45 Since suﬃcient
material for proteomics could not be isolated directly from
intramacrophage Histoplasma yeast, we pursued an alternative
approach whereby proteins were isolated from Histoplasma cells
grown under pathogenic phase-inducing conditions followed by
validation that identiﬁed factors were expressed by Histoplasma
during infection. We attempted to mimic infection conditions
during in vitro culture, yet Histoplasma may produce some
extracellular factors only during residence within the phagocyte
phagosome and these could have been missed. However, these
potential additions to the pathogenic-phase proteome are likely
few since the short time frame during which phagocytosis, the
phagocyte oxidative burst, and intracellular traﬃcking occur
would not allow much time for de novo synthesis of molecules
critical to Histoplasma survival. In support of this, we found that
diﬀerentiation as yeast is suﬃcient for expression of the antiox-
idant defenses superoxide dismutase and catalase. Furthermore,
all of the major yeast-phase enriched extracellular factors are
expressed during infection. Thus, our in vitro-derived extracel-
lular proteome is relevant to Histoplasma pathogenesis in vivo.
The diﬀerent phylogenetic groups of Histoplasma produce
diﬀerent combinations of extracellular yeast-phase virulence
factors.
23 Identiﬁed extracellular factors produced by the North
American 2 class (NAm2) of Histoplasma strains include dipep-
tidyl peptidase and gamma-glutamyltransferase.
12,46 North
America class I Histoplasma strains uniquely secrete an extra-
cellular serine protease.
47 However, none of these enzymes were
foundintheG186Aextracellularproteomepresentedhere.Thus
the extracellular proteomes of the diﬀerent Histoplasma strains
are distinct from one another and our deﬁnition of the extra-
cellular factors produced by the Histoplasma G186A background
may not be fully applicable to that of other phylogenetic groups.
These results also suggest the diﬀerent strain groups may utilize
diﬀerent strategies for pathogenesis.
To provide a high degree of conﬁdence in the protein
identiﬁcations obtained, we used stringent criteria and multiple
linesofevidence.Forinclusioninourﬁnalextracellularproteome
index, we required proteins were (1) present in three indepen-
dent culture ﬁltrate samples, (2) represented by at least two
unique peptides, and (3) deﬁned by both trypsin-derived as well
as chymotrypsin-derived peptides. For deﬁnitive conﬁrmation,
particularly of pathogenic-phase factors that lack signiﬁcant
homology to other deﬁned proteins, we demonstrated that
depletion of candidate factors through genetic means corre-
sponded to loss of speciﬁc proteins from culture ﬁltrates.
Figure5. RNAinterferenceconﬁrmsmassspectrometry-derivedproteinidentities.IndividualextracellularproteinsweretargetedfordepletionbyRNA
interference: Cfp8 and Cfp1 (A), Cfp4 (B), and CatB (C). (A) RNAi-based targeting of Cfp8 (CFP8-RNAi) and Cfp1 (CFP1-RNAi) depletes speciﬁc
proteinbandsincomparisontothecontrol(WT)yeastcultureﬁltrate.ThecontrolcultureﬁltratewasderivedfromHistoplasmayeasttransformedwitha
gfp-RNAi plasmid. Proteins were separated by 10% NextGel SDS-PAGE. (B) RNAi-based silencing of CFP4 expression identiﬁes the Cfp4 band in
deglycosylatedcultureﬁltrates.DeglycosylatedproteinsfromcultureﬁltratesfromtwoindependentCFP4-RNAilineswerecomparedtodeglycosylated
culture ﬁltrate proteins from CFP4(þ) yeast. Yeast culture ﬁltrate proteins were deglycosylated by treatment with the endoglycosidase PNGase F to
remove N-linked oligosaccharides prior to electrophoretic separation. The 36 kDa PNGase F protein migrates just belowthe Cfp4 protein as shown by
the lane containing only the PNGase F protein. Proteins were separated by SDS-PAGE through 12.5% NextGel. (C) RNAi-based depletion and
overexpression conﬁrms the identity of catalase B (CatB). Culture ﬁltrates were prepared from control yeast (CATB(þ)), yeast in which CatB was
silenced by RNAi (CATB-RNAi), and yeast which overexpress CatB (CATB(þþþ)). Culture ﬁltrate proteins were separated by electrophoresis
through 8% denaturing polyacrylamide. All protein bands were visualized by silver staining following electrophoretic separation.1940 dx.doi.org/10.1021/pr1011697 |J. Proteome Res. 2011, 10, 1929–1943
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While any of the identiﬁed extracellular proteins could con-
tribute to Histoplasma virulence, indicators such as (1) abun-
dance,(2)pathogenicphase-enrichedexpression,(3)discernible
signal sequences, and (4) in vivo expression focuses attention on
Chs1, Exg1, Eng1, Cfp1, Cfp4, Cfp8, CatB, Sod3, and Trl1.
Presumably, the exo- and endoglucanases as well as chitinase act
on the yeast glucan- and chitin-rich cell wall during wall
remodeling processes required for yeast growth and replication.
Isotropically growing yeast cells remodel a much greater propor-
tion of their surface than hyphae that elongate at the tips, which
may account for the increased production of the cell wall
degrading enzymes in yeast as compared to mycelia. Release of
the glucanases and chitinase from the cell surface may account
for the presence of these enzymes in yeast cell-free culture
ﬁltrates. Alternatively, extracellular glucanases and chitinase
may reduce potential activation of immune defenses by degrad-
ing glycan fragments released during cell wall remodeling into
smaller, less immunostimulatory oligomers; large chitin and
β-glucan polymers can both stimulate the immune system
through recognition by host PRRs
48,49 whereas small soluble
β-glucans do not activate the β-glucan receptor dectin-1.
48,50-52
The production of extracellular superoxide dismutase and
catalase most likely protect Histoplasma yeast from phagocyte-
derived reactive oxygen molecules. Histoplasma also expresses
two other catalases, CatP and CatA,
53 but their intracellular
localization suggests these two catalases are involved in amelior-
ating fungal-derived oxygen byproducts of metabolism and
respiration. Our results showing increased expression of the
extracellular catalase by Histoplasma yeast cells contrasts with
thatreportedbyJohnson,etal.whoreportedCATBtranscription
in both phases.
53 However, their analysis used a diﬀerent
phylogenetic strain of Histoplasma (NAm2; North American
class 2) and was not quantitative. In the G217B Nam2 strain,
CatB is primarily attached to the yeast cell wall and soluble CatB
appears only after 7 days of culture, which was postulated to
result from cell lysis.
54 In contrast, we ﬁnd abundant CatB in the
cell-free yeast culture ﬁltrate from exponentially growing (1-2
days of culture) G186A yeast cells with no indication of cellular
lysis. While G186A yeast also have cell wall-associated catalase
activity, this represents a minority of the total extracellular
peroxidase activity (data not shown), again reﬂecting diﬀerences
between these two phylogenetically separate strains.
Theextracellularsuperoxidedismutaseidentiﬁedinthisstudy,
Sod3, is a member of a third class of extracellular fungal
dismutase enzymes. In contrast to the intracellular Fe/Mn-
dependent superoxide dismutases associated with mitochondria,
Sod3 is more similar to the Cu/Zn-type superoxide dismutases.
However, Sod3 is not the cytosolic superoxide dismutase ortho-
log since a diﬀerent Histoplasma Cu/Zn Sod protein (Sod1;
HCBG_06622.2) belongs to the clade of eukaryotic cytosolic
superoxide dismutases (Supplemental Figure 3, Supporting
Information). Histoplasma Sod3 is distinct from these cellular
enzymes and shows greater similarity to a group of fungal Cu/
Zn-type superoxide dismutases that all have secretion signals as
dotherelatedmammalianextracellularSod3enzymes.Similarto
CatB, Histoplasma Sod3 is likely produced to speciﬁcally elim-
inate extracellular oxidative stress such as that generated by the
phagocyte NADPH-oxidase in response to microbes. As super-
oxide is a charged molecule unable to cross membranes, intra-
cellular superoxide dismutases are unable to dismute the
superoxide produced in the lumen of the phagosome and would
not provide protection to the yeast. On the other hand, the
extracellular superoxide dismutase Sod3 is precisely positioned
to interact with and destroy the phagocyte-derived superoxide.
The functions of the remaining constituents of the patho-
genic-phase extracellular proteome are more speculative at this
point. The Cfp4 protein is a heavily glycosylated protein
Figure 6. Extracellular proteins are expressed in vivo by Histoplasma
during infection. Transcription of each factor was determined by RT-
PCR of template ribonucleic nucleic acids from Histoplasma yeast,
Histoplasma yeast infecting macrophages (intramacrophage), and His-
toplasma yeast infecting murine lungs (infected lung). For intrama-
crophage transcription, total RNA was puriﬁed from Histoplasma yeast
40 h after infection of P388D1 macrophages. Histoplasma transcription
of genes during respiratory infection was determined by infection of
C57BL/6 mice with Histoplasma yeast for 24 h. Control PCR reactions
wereperformedwithaconstitutivelyexpressedgene(RPS15),amycelia-
enriched gene (MS8), and a yeast-phase speciﬁc factor (CBP1). Geno-
mic DNA was used as template to show the accuracy of each primer set
and band shifts relative to RNA templates correspond to primer sets
which span introns. Reactions lacking reverse-transcription (RT) and
the absence of genomic-sized bands indicate the lack of DNA contam-
ination of RNA templates. PCR products were speciﬁc for Histoplasma
yeast as no products were obtained from uninfected macrophage and
lung reverse-transcribed RNAs. Reverse transcription of RNAs was
primed with random 15-mer and dT 22-mer oligonucleotides. PCR
products were resolved by electrophoresis through 1.5% agarose and
visualized by ethidium bromide staining.1941 dx.doi.org/10.1021/pr1011697 |J. Proteome Res. 2011, 10, 1929–1943
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expressedexclusivelybythepathogenicphase.Serafrompatients
withhistoplasmosiscontainantibodiestothisproteinconﬁrming
Histoplasma yeast produce Cfp4 in vivo.
55 Comparison of
PNGaseF-treated and native culture ﬁltrates indicates N-linked
glycosylation is a hallmark of pathogenic-phase extracellular
proteins suggesting that protein glycosylation is linked to Histo-
plasma virulence. Cfp1 has homology to an allergen from the
fungal pathogen Aspergillus fumigatus but no function has been
described.
56,57
The Histoplasma extracellular proteome also contains a num-
ber of normally cytosolic factors. Although we can not comple-
tely rule out any cellular lysis, three sensitive tests for cytosolic
factors(immunoblotting,PCR,enzymaticassay)disputetheidea
thatthecytosolicproteinsidentiﬁedarefoundintheextracellular
fraction due to cellular leakage. Instead, we suspect that two
diﬀerent mechanisms account for the extracellular localization of
cellular proteins. Membrane-bound peptidyl-prolyl cis-trans
isomerase (Fpr2) and the endoplasmic reticulum protein disul-
ﬁde isomerase (Pdi1) are both abundant constituents of orga-
nellesofthesecretorypathwayandtheirextracellularlocalization
may reﬂect insuﬃcient retention of these chaperone proteins in
suchorganelles.Forthenormallycytosolicfactors,theprocessof
vesicle secretion, a recently demonstrated transport mechanism
for some fungal organisms, including Histoplasma capsulatum, is
likely responsible. In vesicle secretion, cytosolic constituents are
packaged into vesicles and delivered across the cell membrane
and wall into the extracellular milieu.
22 No mechanism or signal
sequence has been described for selectivity of the proteins
transported by this process. Thus abundant cellular proteins
(e.g., TCA cycle enzymes, chaperone molecules, and ribosomal
or translation factors) could enter this alternative secretion
pathway. Consistent with this, the overwhelming majority of
the proteins released by the vesicle secretion transport mecha-
nism are cytosolic factors.
58
Regardless of the transport mechanism, precedent exists for
the unconventional extracellular localization of many of the
cytosolic factors. For example, Hsp90 is found in the Candida
cell wall proteome
59 and mammalian Hsp90 can be secreted
from mammalian cells due to a C-terminal secretion motif.
60
Hsp60 has been found at the yeast cell surface of NAm2
Histoplasma strains where it functions as an adhesin for CD18-
familyreceptors onmacrophages.
61Studieswithothermicrobes,
including fungi, have found metabolic proteins outside of the
cytosol, including phosphoglycerate kinase (Pgk1) and enolase
(Eno1).
59,62-64 In addition to a role in glycolysis, enolases from
Pneumocystis and Leishmania have been shown to bind host
plasminogen.
65,66
One other study has detailed a set of extracellular proteins
released by Histoplasma capsulatum yeast: Albuquerque, et al.
identiﬁed 206 proteins, including ribosomal factors, metabolic
enzymes, cell signaling, and cytoskeletal proteins that were
secreted from Histoplasma yeast through vesicle secretion.
58
Both the study by Albuquerque, et al. and ours use proteomic
approaches; Albuquerque, et al., focused on those proteins
present in extracellular vesicles released from NAm2 yeast, while
our study collected proteins directly from the G186A yeast
culture ﬁltrate. While there is overlap in the identities obtained,
factorsuniquetotheextracellularproteomedeﬁnedbythisstudy
include Eng1, all but Cfp1 of the Cfp proteins, Lpd1, Hom1,
Eno1, and all the oxidative stress defense factors (CatB, Sod3,
Trl1). The catalase identiﬁed by Albuquerque, et al. is not
CatBastheyreported,butisinsteadCatP,aperoxisomalcatalase.
The superoxide dismutases reported in vesicles by Albuquerque,
et al., are most similar to mitochondrial Fe/Mn-type enzymes
andaredistinctfromtheextracellularsuperoxidedismutaseSod3
we identiﬁed.
The unique factors identiﬁed by our study comprise three of
the four most abundant classes of extracellular proteins. Most of
theseuniqueproteins are predicted to have N-terminal secretion
signalssuggestingthetransportofthesereliesuponthecanonical
eukaryotic secretory pathway. On the other hand, most of the
normally cellular proteins (e.g., Cit1, Gdh1, Mpd1,Rad24,Pgk1,
Ssa1, Rpp2, and Ipp1), were found to be delivered to the
extracellular environment through vesicle secretion.
58 The ma-
jority of proteins common between the two studies are normally
cytosolic and they show equivalent or even higher expression in
the nonpathogenic phase. In contrast, most of the extracellular
proteins unique to our study are expressed primarily by the
pathogenic phase, suggesting roles in virulence.
Inconclusion,wehaveidentiﬁedtheabundantconstituentsof
the pathogenic-phase extracellular proteome. In conjunction
with the previously identiﬁed secreted protein Cbp1,
42 this
comprehensivecatalog ofextracellular factorsprovides afounda-
tion for understanding those factors which manipulate the host-
pathogen interface. The preferential expression of many of these
extracellular proteins by pathogenic-phase cells makes them
prime candidates for reverse genetic approaches to dissect
Histoplasma pathogenesis. While random mutagenesis strategies
are an alternative approach, they are limited to deﬁning one
factor at a time. Since pathogenesis is multifactorial, the index of
extracellular factors determined through proteomics provides a
more complete framework for deciphering the multiple aspects
of Histoplasma virulence.
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